preconception counselling

in review 4 min read Updated 2026-10-15
preconception counselling

Disease control at conception predicts outcome. Three moves: (1) defer conception until optimised, with effective contraception meanwhile; (2) swap teratogens and start folic acid (0.4 / 1 / 4–5 mg by risk); (3) plan care — MFM ± subspecialist referral, aspirin eligibility, “tell me as soon as you’re pregnant”.

do not miss — advise against pregnancy or defer

mWHO 2.0 IV: PAH, LVEF <30% or NYHA III–IV, prior PPCM with > mild residual LV impairment, severe MS, symptomatic severe AS, Marfan/HTAD aorta >45 mm (BAV >50), vascular EDS, Eisenmenger. Also defer: mechanical valve (mWHO III) without anticoagulation plan, active lupus nephritis/SLE flare within 6 months, HbA1c >10%, uncontrolled epilepsy on valproate, eGFR <30 or recent transplant (<1 y).

folic acid (SOGC)

riskdose
low0.4 mg/d in a multivitamin (with B12 + iron), from 2–3 months pre-conception through pregnancy and breastfeeding
moderate — pre-gestational T1/T2DM, antiseizure drugs (AAN 2024: ≥0.4 mg), malabsorption (IBD, coeliac, bariatric), anti-folate drugs (MTX, sulfasalazine), dialysis, second-degree relative with NTD, BMI >30 (consider serum folate)1 mg/d pre-conception to 12 wk, then 0.4 mg
high — prior NTD pregnancy (either parent), personal NTD, or first-degree relative with NTD4–5 mg/d pre-conception to 12 wk (or dose by serum folate), then 0.4 mg

by condition

conditionkey preconception actionsmain risks
chronic HTNreplace ACEi/ARB when planning pregnancy (at positive test if compelling indication, e.g. proteinuria); labetalol/nifedipine; baseline uPCR, Crsuperimposed preeclampsia, FGR, abruption — chronic hypertension in pregnancy
T1/T2DMHbA1c ≤7% (ideally ≤6.5%); retinal exam, uACR; stop non-insulin agents except metformin/glyburide; folate 1 mganomalies, stillbirth 3–5×, macrosomia, preeclampsia — diabetes in pregnancy
prior preeclampsiaaspirin 162 mg qhs before 16 wk; exercise ≥150 min/wk; BP, lipids, glucose screenrecurrence ~1 in 6; ~25% if prior <34 wk, ~50% if <28 wk
prior GDMscreen for T2DM; weight, activity~50% recurrence
epilepsyswitch from valproate/topiramate; baseline levels; folateMCM, seizures if under-dosed — epilepsy in pregnancy
heart diseaseecho, mWHO class, cardio-obstetrics; intervene on severe stenosisHF, arrhythmia — heart disease in pregnancy
prior VTEplan antepartum/postpartum LMWHrecurrence 5–10% without prophylaxis — VTE in pregnancy
SLE / APSquiescent ≥6 months; continue HCQ; stop MMF >6 wk and MTX 1–3 months pre-conception; anti-Ro/La, aPLflare, preeclampsia, congenital heart block (anti-Ro → foetal echo 16–26 wk)
IBDsteroid-free remission ≥3 months; continue 5-ASA, azathioprine, anti-TNF; stop MTX ≥3 monthsflare (active at conception ~⅔ flare vs ~⅓ in remission), preterm birth
CKDeGFR, proteinuria, BP control; stop ACEi at positive testpreeclampsia, CKD progression if Cr >125 µmol/L
thyroidlevothyroxine-treated → ↑ dose ~25–30% (2 extra tablets/wk) at positive test; aim euthyroid preconception (ATA 2026); switch methimazole → PTU before 16 wk if hyperthyroidmiscarriage, preeclampsia, preterm birth, neurodevelopmental delay — thyroid disease in pregnancy
obesity (BMI >30)weight loss pre-conception; 1 mg folate; screen for DM/OSAGDM, preeclampsia, VTE, NTD, stillbirth, CS

lifestyle and general

  • Stop smoking, alcohol, cannabis
  • Exercise: ≥150 min/wk moderate intensity over ≥3 days throughout pregnancy unless contraindicated (SOGC: ~40% ↓ GDM, gestational HTN, preeclampsia)
  • Vaccinate pre-conception: MMR, varicella if non-immune (then wait 4 wk); HBV, influenza, COVID
  • Medication review against teratogen list — prescribing in pregnancy and lactation
  • Statins: stop when planning pregnancy for primary prevention; continuation may be considered with FH or established ASCVD (ESC 2025)

obesity in pregnancy

  • Gestational weight gain (IOM, BMI ≥30): 5–9 kg
  • BMI >30 = high-risk factor for preeclampsia (SOGC 2022) → aspirin; early GDM screen
  • Anaesthesia consult antenatally (BMI ≥40); postpartum thromboprophylaxis after CS
  • Postpartum: depression screening, lactation support

IBD in pregnancy

  • Mode of delivery obstetric — except active perianal Crohn’s (→ CS) and IPAA (discuss)
  • Flare: prednisone, 5-ASA, anti-TNF (GI-led)
  • Anti-TNF-exposed infants: rotavirus on schedule; delay BCG 6 months if infliximab/adalimumab/golimumab after 20 wk (etanercept after 32 wk); certolizumab — no change
  • Non-TNF biologics (e.g. ustekinumab) in T2–T3 → delay all live vaccines 6 months
  • Chronic steroids: stress-dose for caesarean, not routinely for vaginal delivery (ACR, conditional)
counselling script

“The better your condition is controlled before conception, the safer the pregnancy is for you and the baby. Until then, use reliable contraception. When you’re ready, start folic acid three months ahead, and tell me as soon as you’re pregnant so I can refer you to maternal–foetal medicine.”

Prepared 2026-10-15. Not yet verified — check every number against the sources.

Key references

+5 more sources

Suggest a correction preconception counselling